Bal Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 to consider and approve un-audited standalone and consolidated financial results of the company for the quarter and half year ended 30.09.2024.
The above information is a part of company’s filings submitted to BSE.